Aptevo Therapeutics (APVO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

APVO Aptevo Therapeutics

Watchlist

0.280
-0.065-18.88%

Close Nov 29 13:00 ET

0.281
+0.001+0.21%

Post 17:01 ET

5.19MMarket Cap-24P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Top Midday Decliners
MT NewswiresNov 29 12:58 ET
What's Going On With Aptevo Therapeutics Shares Friday?
BenzingaNov 29 12:25 ET
Express News | Aptevo Therapeutics Inc - Announces 1-for 37 Reverse Stock Split as Part of Nasdaq Compliance Plan
ReutersNov 29 09:56 ET
Aptevo Therapeutics Announces 1-for 37 Reverse Stock Split As Part of Nasdaq Compliance Plan
AccesswireNov 29 09:55 ET
Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation
AccesswireNov 26 08:35 ET
Express News | Aptevo Provided Details About Portfolio On Cancer Immunotherapy
BenzingaNov 22 08:37 ET

Comments

Stock_Drift

Nov 29 09:48

12/3/24 R/S 🚨🚨🚨

$Aptevo Therapeutics (APVO.US)$

Jaguar8

Nov 29 08:57

NEWS

$Aptevo Therapeutics (APVO.US)$
Aptevo Therapeutics Announces 1-for 37 Reverse Stock Split As Part of Nasdaq Compliance Plan- December 3

Jaguar8

Nov 26 07:38

NEWS

$Aptevo Therapeutics (APVO.US)$
Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation
Aptevo Therapeutics (NASDAQ:APVO) announced that Peter Pavlik, PhD, Senior Director of Protein Engineering, will chair a session and present at Cambridge Healthcare Institute's Pep Talk conference in January 2025.
The presentation will showcase how Aptevo uses its ADAPTIR and ADAPTIR-FLEX platforms to accelerate cancer therapy developme...